Seacross Pharma (Europe) Limited

Poland

All drugs from this manufacturer

  • AZACITIDINE DELFARMA

    The medicine is used in adults who are not candidates for stem cell transplantation, for the treatment of high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).

    Dosage form: powder for preparation of injection suspension

    Active substance Dosage
    azacitidine 25 mg/ml

    ATC: L01BC07

  • AZCULEM

    The medicine is used in adults for the treatment of high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML). These are diseases that affect the bone marrow.

    Dosage form: powder for preparation of injection suspension

    Active substance Dosage
    azacitidine 100 mg/ml

    ATC: L01BC07

  • PLERIXAFOR BIOFAR

    The medicine is used to facilitate the collection of hematopoietic stem cells for subsequent storage and transplantation. It is intended for adults with lymphoma or multiple myeloma and for children (from 1 to 18 years of age) with lymphoma or solid tumors.

    Dosage form: solution for injection

    Active substance Dosage
    plerixafor 20 mg/ml

    ATC: L03AX16